神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长

ACN新闻在线能提供全方位的服务。对于希望向媒体、业界和金融市场披露和传播信息的公司和组织，我们能为您安排实时的新闻发布。ACN新闻在线的新闻稿包括英文、简体中文、繁体中文、韩文和日文等多种语言版本。

Monday, 30 November 2020, 14:00 HKT/SGT

来源 China Shineway Pharmaceutical Group Limited

香港, 2020年11月30日 - (亚太商讯) - 神威药业（股份代號：02877.HK）於二零二零年十月份单月营业额比去年同期录得29.4%增长，其中注射液产品、软胶囊产品、颗粒剂产品、中药配方颗粒、及其他剂型产品营业额分别上升了38.9%， 17.4%，38.1%，7.9%，及 54.0% 。

话题 Press release summary

部门健康与医药
http://www.acnnewswire.com
From the Asia Corporate News Network

Latest Press Releases

MHIEC Receives Contract for Improvement of Core Equipment at Municipal Solid Waste Incineration Facility in Kanazawa Thursday, October 16, 2025 10:57:00 PM

Canada Backs Advanced Tokenization and Distributed Federated Learning Research with Over $3 Million in Funding Oct 16, 2025 22:45 HKT/SGT

Overview of Honda Exhibits at Japan Mobility Show 2025 Thursday, October 16, 2025 10:20:00 PM

DENSO to Exhibit at JAPAN MOBILITY SHOW 2025 Thursday, October 16, 2025 9:53:00 PM

Fujitsu and IISc launch joint research on advanced AI technologies to accelerate new material development and resolve societal challenges Thursday, October 16, 2025 8:55:00 PM

Kincora Appoints Kerry Stevenson and Michelle Borromeo to the Advisory Board Oct 16, 2025 20:09 HKT/SGT

45th Electronics Fair and electronicAsia attract some 60,000 buyers Oct 16, 2025 19:06 HKT/SGT

Radisson Expands Ongoing Step-Out Drill Program at O'Brien to 140,000 Metres Oct 16, 2025 18:39 HKT/SGT

How DPC Dash-Domino's Pizza China Is Capturing China's Pizza Market Oct 16, 2025 14:30 HKT/SGT

SERES Passes HKEX Listing Hearing - First 'A+H' Dual-Listed Premium NEV Maker Poised for Hong Kong Debut Oct 16, 2025 14:28 HKT/SGT


More Press release >>


顶部 \| 关于我们 \| 服务 \| 合作伙伴 \| 联系人 \| 隐私权政策 \| 使用条款 \| RSS

美国： +1 214 890 4418 \| 中国： +86 181 2376 3721 \| 香港： +852 8192 4922 \| 新加坡： +65 6549 7068 \| 东京： +81 3 6859 8575